| |
|
|
|
ENDRA Life Sciences Inc.  
|
|
1.477 -0.013 (-0.01%) |
07-22 09:36 |
|
Open: |
1.46 |
Pre close: |
1.49 |
Target:
|
2.15 
|
|
High: |
1.477 |
Low: |
1.45 |
Resistance:
|
1.84
2.11
|
|
Volume: |
3,393 |
Market Cap: |
11M |
Support:
|
1.40
1.16
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.49
 |
MACD |
MACD(12,26):
|
-0.00 |
|
MA(20): |
1.62 |
Signal(12,26,9): |
0.02 |
|
MA(100): |
1.66 |
Stochastic Oscillator |
%K(14,3):
|
10.72 |
|
MA(250): |
2.31 |
%D(3): |
12.57 |
|
Average Volume(K) |
3-Month: |
13714
|
52-Week |
High:
|
5.75 |
|
10-Days: |
7202 |
Low: |
0.90 |
|
RSI |
RSI(14):
|
47.64 |
Change(%): |
-28.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.807 |
Return on Equity (ttm) |
-293.1 |
Shares Out. (M) |
3.92 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-129.7 |
Shares Float (M) |
7.12 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
3.51 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
18.35 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.002 |
Shares Short (K) |
719 |
|
Book Value (p.s.) |
0.510 |
EBITDA (p.s.) |
-2.186 |
P/E |
-0.82 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.92 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-7.79 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-3.58 |
P/CF |
-0.75 |
|
|
|
|
|
|
